Hong Kong Stock Exchange · Healthcare
Invest in Qianhai Health stock from India
Indian and foreign residents can buy Qianhai Health (911) shares directly through Paasa.
By Paasa · Updated
Qianhai Health at a glance
- Price
- HK$0.38+HK$0.01 (2.70%)
- Market cap
- HK$64.39M
- Day range
- HK$0.38 – HK$0.39
- P/E
- 16.03
- Dividend yield
- None
- Volume
- 30.00K
- 1 month
- -27.62%
- 6 months
- +40.74%
- YTD
- +38.18%
- 1 year
- +46.15%
- 5 years
- -58.70%
Qianhai Health statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | HK$677.1M | HK$519.7M | HK$961.3M | HK$2.0B | HK$283.4M |
| Gross profit | HK$22.3M | HK$29.7M | −HK$35.6M | HK$76.5M | HK$16.0M |
| Operating income | HK$5.7M | HK$13.9M | −HK$52.7M | −HK$163.9M | −HK$16.1M |
| Net income | HK$5.9M | HK$1.3M | −HK$52.7M | −HK$233.7M | −HK$888.0K |
| Earnings per share | HK$0.04 | HK$0.01 | −HK$0.03 | −HK$1.38 | −HK$0.01 |
| EBITDA | HK$7.4M | HK$15.6M | −HK$50.2M | −HK$231.2M | HK$2.1M |
| Total assets | HK$408.4M | HK$407.3M | HK$478.1M | HK$534.4M | HK$738.6M |
| Total debt | HK$424.0K | HK$1.0M | HK$487.0K | HK$1.2M | HK$7.8M |
| Cash and short-term investments | HK$61.4M | HK$23.5M | HK$19.5M | HK$1.6M | HK$2.5M |
| Shareholders' equity | HK$391.2M | HK$385.6M | HK$384.1M | HK$436.7M | HK$670.5M |
| Operating cash flow | HK$38.8M | HK$4.2M | HK$857.0K | −HK$5.3M | −HK$44.2M |
| Free cash flow | HK$38.8M | HK$4.2M | HK$857.0K | −HK$5.3M | −HK$44.2M |
| Capital expenditure | −HK$14.0K | −HK$7.0K | HK$0.0 | −HK$4.0K | −HK$9.0K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in HKD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| PuraPharm | 1498.HK | HK$0.26 | HK$136.44M |
| Grand Brilliance | 8372.HK | HK$0.15 | HK$122.40M |
| Wanjia | 0401.HK | HK$0.10 | HK$116.25M |
| Medicskin | 8307.HK | HK$0.17 | HK$68.64M |
| Raily Aesthetic Medicine International | 2135.HK | HK$0.12 | HK$66.29M |
| Elegance Optical International | 0907.HK | HK$0.06 | HK$53.24M |
| Pa Shun International | 0574.HK | HK$0.02 | HK$39.82M |
| MaxWin International | 8513.HK | HK$0.30 | HK$24.14M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Qianhai Health from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 911 and buy
Find Qianhai Health by name or by its ticker, 911, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Qianhai Health from India
What Qianhai Health does
Qianhai Health Holdings Limited (0911.HK) functions as an investment holding company primarily focused on the distribution of health products and electronic components within Hong Kong. Its operations are structured into two main divisions: Health-Care Products and Electronic Component Products. Qianhai Health operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Qianhai Health stock from India?
Yes. Indian residents and NRIs can buy Qianhai Health (911) shares directly through Paasa. Qianhai Health is listed on the Hong Kong Stock Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Qianhai Health share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$0.38 a share, size the order by the lot, not by the share.
What tax do I pay in India when I sell Qianhai Health shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Would my heirs owe estate tax on Qianhai Health shares?
Hong Kong has no estate duty. That is the source-country side; the shares themselves pass on like any other asset you hold in your own name.